Is TP53 Mutated AML the Same Disease as TP53 Mutated MDS?

被引：0
作者：
Valk, Peter J. M. [1 ]
机构：
[1] Univ Med Ctr Rotterdam, Erasmus MC Canc Inst, Dept Hematol, Rotterdam, Netherlands
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2022年 / 22卷
关键词：
AML; MDS-EB; TP53; mutation; outcome; ALLELE FREQUENCY; MUTATIONS; OUTCOMES;
D O I：
10.1016/S2152-2650(22)00640-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S3 / S5
页数：3
相关论文
共 19 条
  • [1] Implications ofTP53allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
    Bernard, Elsa
    Nannya, Yasuhito
    Hasserjian, Robert P.
    Devlin, Sean M.
    Tuechler, Heinz
    Medina-Martinez, Juan S.
    Yoshizato, Tetsuichi
    Shiozawa, Yusuke
    Saiki, Ryunosuke
    Malcovati, Luca
    Levine, Max F.
    Arango, Juan E.
    Zhou, Yangyu
    Sole, Francesc
    Cargo, Catherine A.
    Haase, Detlef
    Creignou, Maria
    Germing, Ulrich
    Zhang, Yanming
    Gundem, Gunes
    Sarian, Araxe
    van de Loosdrecht, Arjan A.
    Jadersten, Martin
    Tobiasson, Magnus
    Kosmider, Olivier
    Follo, Matilde Y.
    Thol, Felicitas
    Pinheiro, Ronald F.
    Santini, Valeria
    Kotsianidis, Ioannis
    Boultwood, Jacqueline
    Santos, Fabio P. S.
    Schanz, Julie
    Kasahara, Senji
    Ishikawa, Takayuki
    Tsurumi, Hisashi
    Takaori-Kondo, Akifumi
    Kiguchi, Toru
    Polprasert, Chantana
    Bennett, John M.
    Klimek, Virginia M.
    Savona, Michael R.
    Belickova, Monika
    Ganster, Christina
    Palomo, Laura
    Sanz, Guillermo
    Ades, Lionel
    Della Porta, Matteo Giovanni
    Smith, Alexandra G.
    Werner, Yesenia
    [J]. NATURE MEDICINE, 2020, 26 (10) : 1549 - +
  • [2] A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies
    Boettcher, Steffen
    Miller, Peter G.
    Sharma, Rohan
    McConkey, Marie
    Leventhal, Matthew
    Krivtsov, Andrei V.
    Giacomelli, Andrew O.
    Wong, Waihay
    Kim, Jesi
    Chao, Sherry
    Kurppa, Kari J.
    Yang, Xiaoping
    Milenkowic, Kirsten
    Piccioni, Federica
    Root, David E.
    Ruecker, Frank G.
    Flamand, Yael
    Neuberg, Donna
    Lindsley, R. Coleman
    Janne, Pasi A.
    Hahn, William C.
    Jacks, Tyler
    Doehner, Hartmut
    Armstrong, Scott A.
    Ebert, Benjamin L.
    [J]. SCIENCE, 2019, 365 (6453) : 599 - +
  • [3] Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations
    Ciurea, Stefan O.
    Chilkulwar, Abhishek
    Saliba, Rima M.
    Chen, Julianne
    Rondon, Gabriela
    Patel, Keyur P.
    Khogeer, Haitham
    Shah, Abdul R.
    Randolph, Brion V.
    Perez, Jorge M. Ramos
    Popat, Uday
    Hosing, Chitra M.
    Bashir, Qaiser
    Mehta, Rohtesh
    Al-Atrash, Gheath
    Im, Jin
    Khouri, Issa F.
    Kebriaei, Partow
    Champlin, Richard E.
    [J]. BLOOD, 2018, 131 (26) : 2989 - 2992
  • [4] Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
    Doehner, Hartmut
    Estey, Elihu
    Grimwade, David
    Amadori, Sergio
    Appelbaum, Frederick R.
    Buechner, Thomas
    Dombret, Herve
    Ebert, Benjamin L.
    Fenaux, Pierre
    Larson, Richard A.
    Levine, Ross L.
    Lo-Coco, Francesco
    Naoe, Tomoki
    Niederwieser, Dietger
    Ossenkoppele, Gert J.
    Sanz, Miguel
    Sierra, Jorge
    Tallman, Martin S.
    Tien, Hwei-Fang
    Wei, Andrew H.
    Lowenberg, Bob
    Bloomfield, Clara D.
    [J]. BLOOD, 2017, 129 (04) : 424 - 447
  • [5] Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome
    Grob, Tim
    Al Hinai, Adil S. A.
    Sanders, Mathijs A.
    Kavelaars, Francois G.
    Rijken, Melissa
    Gradowska, Patrycja L.
    Biemond, Bart J.
    Breems, Dimitri A.
    Maertens, Johan
    Kooy, Marinus van Marwijk
    Pabst, Thomas
    de Weerdt, Okke
    Ossenkoppele, Gert J.
    van de Loosdrecht, Arjan A.
    Huls, Gerwin A.
    Cornelissen, Jan J.
    Beverloo, H. Berna
    Lowenberg, Bob
    Jongen-Lavrencic, Mojca
    Valk, Peter J. M.
    [J]. BLOOD, 2022, 139 (15) : 2347 - 2354
  • [6] Molecular Minimal Residual Disease in Acute Myeloid Leukemia
    Jongen-Lavrencic, M.
    Grob, T.
    Hanekamp, D.
    Kavelaars, F. G.
    al Hinai, A.
    Zeilemaker, A.
    Erpelinck-Verschueren, C. A. J.
    Gradowska, P. L.
    Meijer, R.
    Cloos, J.
    Biemond, B. J.
    Graux, C.
    Kooy, M. van Marwijk
    Manz, M. G.
    Pabst, T.
    Passweg, J. R.
    Havelange, V.
    Ossenkoppele, G. J.
    Sanders, M. A.
    Schuurhuis, G. J.
    Lowenberg, B.
    Valk, P. J. M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (13) : 1189 - 1199
  • [7] Putting p53 in Context
    Kastenhuber, Edward R.
    Lowe, Scott W.
    [J]. CELL, 2017, 170 (06) : 1062 - 1078
  • [8] Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
    Ley, Timothy J.
    Miller, Christopher
    Ding, Li
    Raphael, Benjamin J.
    Mungall, Andrew J.
    Robertson, A. Gordon
    Hoadley, Katherine
    Triche, Timothy J., Jr.
    Laird, Peter W.
    Baty, Jack D.
    Fulton, Lucinda L.
    Fulton, Robert
    Heath, Sharon E.
    Kalicki-Veizer, Joelle
    Kandoth, Cyriac
    Klco, Jeffery M.
    Koboldt, Daniel C.
    Kanchi, Krishna-Latha
    Kulkarni, Shashikant
    Lamprecht, Tamara L.
    Larson, David E.
    Lin, Ling
    Lu, Charles
    McLellan, Michael D.
    McMichael, Joshua F.
    Payton, Jacqueline
    Schmidt, Heather
    Spencer, David H.
    Tomasson, Michael H.
    Wallis, John W.
    Wartman, Lukas D.
    Watson, Mark A.
    Welch, John
    Wendl, Michael C.
    Ally, Adrian
    Balasundaram, Miruna
    Birol, Inanc
    Butterfield, Yaron
    Chiu, Readman
    Chu, Andy
    Chuah, Eric
    Chun, Hye-Jung
    Corbett, Richard
    Dhalla, Noreen
    Guin, Ranabir
    He, An
    Hirst, Carrie
    Hirst, Martin
    Holt, Robert A.
    Jones, Steven
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (22) : 2059 - 2074
  • [9] Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia
    Metzeler, Klaus H.
    Herold, Tobias
    Rothenberg-Thurley, Maja
    Amler, Susanne
    Sauerland, Maria C.
    Gorlich, Dennis
    Schneider, Stephanie
    Konstandin, Nikola P.
    Dufour, Annika
    Braundl, Kathrin
    Ksienzyk, Bianka
    Zellmeier, Evelyn
    Hartmann, Luise
    Greif, Philipp A.
    Fiegl, Michael
    Subklewe, Marion
    Bohlander, Stefan K.
    Krug, Utz
    Faldum, Andreas
    Berdel, Wolfgang E.
    Wormann, Bernhard
    Buchner, Thomas
    Hiddemann, Wolfgang
    Braess, Jan
    Spiekermann, Karsten
    [J]. BLOOD, 2016, 128 (05) : 686 - 698
  • [10] Genomic context and TP53 allele frequency define clinical outcomes in TP53-mutated myelodysplastic syndromes
    Montalban-Bravo, Guillermo
    Kanagal-Shamanna, Rashmi
    Benton, Christopher B.
    Class, Caleb A.
    Chien, Kelly S.
    Sasaki, Koji
    Naqvi, Kiran
    Alvarado, Yesid
    Kadia, Tapan M.
    Ravandi, Farhad
    Daver, Naval
    Takahashi, Koichi
    Jabbour, Elias
    Borthakur, Gautham
    Pemmaraju, Naveen
    Konopleva, Marina
    Soltysiak, Kelly A.
    Pierce, Sherry R.
    Bueso-Ramos, Carlos E.
    Patel, Keyur P.
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    [J]. BLOOD ADVANCES, 2020, 4 (03) : 482 - 495
12